Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9353100
APP PUB NO 20120207703A1
SERIAL NO

13370198

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, and pharmaceutical compositions and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IDENIX PHARMACEUTICALS LLC320 BENT STREET CAMBRIDGE MA 02141

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alexandre, Francois-Rene Montpellier, FR 29 506
Convard, Thierry Sathonay-Camp, FR 14 174
Parsy, Christophe Claude Jacou, FR 31 549
Surleraux, Dominique Wauthier-Braine, BE 35 756

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 30, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00